Literature DB >> 6098299

Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli.

D G Brenner, J R Knowles.   

Abstract

When penicillanic acid sulfone in large molar excess is incubated with the RTEM beta-lactamase, the enzyme becomes inactivated irreversibly. From studies of the consequential spectroscopic changes, from the use of specifically tritiated penicillanic acid sulfone, and from comparison by isoelectric focusing of the enzyme after inactivation by the sulfone and by clavulanic acid, the inactivated enzyme appears to be cross-linked by a beta-aminoacrylate fragment deriving from C-5, C-6, and C-7 of the original beta-lactam. Model studies on the behavior of alcoholic solutions of penicillanic acid sulfone in the presence of amines are entirely consistent with this interpretation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098299     DOI: 10.1021/bi00319a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.

Authors:  A K Knap; R F Pratt
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

2.  Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.

Authors:  Pius S Padayatti; Anjaneyulu Sheri; Monica A Totir; Marion S Helfand; Marianne P Carey; Vernon E Anderson; Paul R Carey; Christopher R Bethel; Robert A Bonomo; John D Buynak; Focco van den Akker
Journal:  J Am Chem Soc       Date:  2006-10-11       Impact factor: 15.419

3.  Kinetic study of two novel enantiomeric tricyclic beta-lactams which efficiently inactivate class C beta-lactamases.

Authors:  M Vilar; M Galleni; T Solmajer; B Turk; J M Frère; A Matagne
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

4.  Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.

Authors:  Monica A Totir; Pius S Padayatti; Marion S Helfand; Marianne P Carey; Robert A Bonomo; Paul R Carey; Focco van den Akker
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

5.  β-Lactamase inhibition by 7-alkylidenecephalosporin sulfones: allylic transposition and formation of an unprecedented stabilized acyl-enzyme.

Authors:  Elizabeth A Rodkey; David C McLeod; Christopher R Bethel; Kerri M Smith; Yan Xu; Weirui Chai; Tao Che; Paul R Carey; Robert A Bonomo; Focco van den Akker; John D Buynak
Journal:  J Am Chem Soc       Date:  2013-12-03       Impact factor: 15.419

6.  Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate.

Authors:  Jean-Emmanuel Hugonnet; John S Blanchard
Journal:  Biochemistry       Date:  2007-10-04       Impact factor: 3.162

7.  Biosynthetic Incorporation of Site-Specific Isotopes in β-Lactam Antibiotics Enables Biophysical Studies.

Authors:  Jacek Kozuch; Samuel H Schneider; Steven G Boxer
Journal:  ACS Chem Biol       Date:  2020-03-20       Impact factor: 5.100

8.  Irreversible inactivation of beta-lactamase I from Bacillus cereus by chlorinated 6-spiroepoxypenicillins.

Authors:  L Gledhill; P Williams; B W Bycroft
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

Review 9.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Clavulanate inactivation of Staphylococcus aureus beta-lactamase.

Authors:  I Rizwi; A K Tan; A L Fink; R Virden
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.